Stay updated on NIZ985 and Spartalizumab Clinical Trial
Sign up to get notified when there's something new on the NIZ985 and Spartalizumab Clinical Trial page.

Latest updates to the NIZ985 and Spartalizumab Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedFooter changes include the addition of Revision: v3.3.3 and removal of HHS Vulnerability Disclosure and Revision: v3.3.2; these are minor maintenance updates that do not affect study content or user-facing functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check17 days agoNo Change Detected
- Check24 days agoNo Change Detected
- Check38 days agoChange DetectedThe page's revision stamp updates from v3.2.0 to v3.3.2.SummaryDifference0.1%

- Check45 days agoChange DetectedThe page no longer shows the government funding lapse notice that warned information may not be up to date and that transactions might not be processed, and it no longer references the NIH Clinical Center status or opm.gov. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check59 days agoChange DetectedA newer version entry (2025-05-01) was added to the Record History, introducing updated status information while the page layout remains the same.SummaryDifference0.1%

- Check88 days agoChange DetectedNew operating-status notice and version update to v3.2.0; previous v3.1.0 version tag removed.SummaryDifference11%

- Check95 days agoChange DetectedChanged the revision from v3.0.2 to v3.1.0, indicating a minor version update with no other content changes.SummaryDifference0.3%

Stay in the know with updates to NIZ985 and Spartalizumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the NIZ985 and Spartalizumab Clinical Trial page.